Advertisement
UK markets closed
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • CRUDE OIL

    82.54
    -0.27 (-0.33%)
     
  • GOLD FUTURES

    2,341.50
    +3.10 (+0.13%)
     
  • DOW

    38,007.06
    -453.86 (-1.18%)
     
  • Bitcoin GBP

    51,627.10
    -250.22 (-0.48%)
     
  • CMC Crypto 200

    1,391.46
    +8.89 (+0.64%)
     
  • NASDAQ Composite

    15,544.66
    -168.09 (-1.07%)
     
  • UK FTSE All Share

    4,387.94
    +13.88 (+0.32%)
     

Gilead Will Boost HIV, NASH Drugs Amid Hep C Slump; Stock On 2-Week Dip

Gilead Will Boost HIV, NASH Drugs Amid Hep C Slump; Stock On 2-Week Dip

Gilead will bulk up its HIV and NASH units even as its Hep C drug sales crumble, Needham analyst Alan Carr said Friday.